Literature DB >> 84294

Mycobacteria and inflammatory bowel disease.

J L Stanford, S A White, W R Burnham, J E Lennard-Jones, R G Bird.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 84294     DOI： 10.1016/s0140-6736(79)90922-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.

Authors:  G L Swift; E D Srivastava; R Stone; R D Pullan; R G Newcombe; J Rhodes; S Wilkinson; P Rhodes; G Roberts; B W Lawrie
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

Review 2.  Progress and frustration in inflammatory bowel disease.

Authors:  B N Brooke
Journal:  Ann R Coll Surg Engl       Date:  1980-11       Impact factor: 1.891

3.  Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study.

Authors:  G A Thomas; G L Swift; J T Green; R G Newcombe; C Braniff-Mathews; J Rhodes; S Wilkinson; G Strohmeyer; G Kreuzpainter
Journal:  Gut       Date:  1998-04       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.